Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1 billion, the Wall Street Journal reported on ...

Eli Lilly (LLY 3.74%) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in ...

Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly to ...

Eli Lilly and Nimbus Therapeutics have entered into a multi-year collaboration and exclusive licensing agreement to develop ...

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

In the latest trading session, Eli Lilly (LLY) closed at $1,041.51, marking a -3.6% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.64% for the day.

Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...

It’s the latest move in the race by drug companies to corner more of the highly-lucrative obesity drug market.

Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his ...